Hanyu Group(300403)
Search documents
汉宇集团:第五届监事会第六次会议决议公告
2024-04-28 07:44
证券代码:300403 证券简称:汉宇集团 公告编号:2024-022 汉宇集团股份有限公司 第五届监事会第六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 1、审议通过了《2024 年第一季度报告》 经审核,监事会认为董事会编制和审核公司 2024 年第一季度报告的程序符 合法律、行政法规和中国证监会的规定,报告内容真实、准确、完整地反映了公 司的实际情况,不存在任何虚假记载、误导性陈述或者重大遗漏。 表决结果:3 票同意,0 票反对,0 票弃权,表决通过。 三、备查文件 1、第五届监事会第六次会议决议 一、监事会会议召开情况 汉宇集团股份有限公司(以下简称"公司")第五届监事会第六次会议(以 下简称"本次会议")于 2024 年 4 月 26 日以通讯表决的方式召开,本次会议由 监事会主席曹阳先生主持,应参与表决监事 3 人,实际表决监事 3 人。 本次会议通知于 2024 年 4 月 19 日以邮件方式发出,会议召开符合《中华人 民共和国公司法》《公司章程》的规定,会议召开合法、有效。 二、监事会会议审议情况 经与会监事认真审议本次会议议 ...
汉宇集团(300403) - 2024 Q1 - 季度财报
2024-04-28 07:42
Financial Performance - The company's revenue for Q1 2024 was CNY 266,120,434.97, representing a 4.00% increase compared to CNY 255,890,736.37 in the same period last year[4]. - Net profit attributable to shareholders increased by 20.97% to CNY 56,780,429.98 from CNY 46,938,824.33 year-on-year[4]. - Basic and diluted earnings per share rose by 21.08% to CNY 0.0942, compared to CNY 0.0778 in the same period last year[4]. - Net profit for Q1 2024 was CNY 56,780,429.98, up 24% from CNY 45,866,779.69 in the same period last year[18]. - Earnings per share (EPS) for Q1 2024 was CNY 0.0942, compared to CNY 0.0778 in Q1 2023, reflecting a growth of 21.5%[18]. - The company reported a comprehensive income total of CNY 58,137,082.55 for Q1 2024, compared to CNY 53,366,635.74 in Q1 2023, an increase of 8.5%[18]. Cash Flow - The net cash flow from operating activities decreased by 18.44% to CNY 61,961,596.20, down from CNY 75,967,600.70 in the previous year[4]. - The total cash inflow from operating activities was ¥288,716,203.21, slightly up from ¥287,036,660.86 in the previous year[21]. - The cash outflow from operating activities totaled ¥226,754,607.01, compared to ¥211,069,060.16 in Q1 2023, indicating an increase of 7.4%[21]. - The net cash flow from investing activities was -¥8,881,704.39, a significant decline from a positive cash flow of ¥25,715,893.49 in the same quarter last year[21]. - Cash inflow from financing activities was ¥16,220,864.78, up from ¥3,000,000.00 in Q1 2023[22]. - The net cash flow from financing activities was -¥5,263,460.36, an improvement from -¥13,941,045.37 in the previous year[22]. - The total cash and cash equivalents at the end of Q1 2024 amounted to ¥181,793,947.44, an increase from ¥172,135,413.56 at the end of Q1 2023[22]. - The company received tax refunds of ¥8,123,786.64, compared to ¥3,231,210.60 in the previous year, showing a significant increase[21]. - The cash paid for purchasing goods and services was ¥147,157,455.15, up from ¥134,188,746.98 in Q1 2023, reflecting a growth of 9.4%[21]. - The cash paid to employees was ¥43,536,689.59, a decrease from ¥46,463,224.38 in the same quarter last year[21]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,406,659,187.90, a 1.65% increase from CNY 2,367,540,561.84 at the end of the previous year[4]. - The company's total liabilities decreased to CNY 407,591,803.96 from CNY 412,557,904.95, a decline of 1.1%[17]. - The total equity attributable to shareholders increased to CNY 1,999,067,383.94 from CNY 1,954,982,656.89, marking a growth of 2.3%[17]. - The total number of common stock shareholders at the end of the reporting period is 32,631[9]. - The company's total non-current assets decreased to ¥1,447,560,433.92 from ¥1,496,133,419.15, a decline of approximately 3.3%[13]. Shareholder Information - The top shareholder, Shi Huashan, holds 213,087,472 shares, representing 35.34% of total shares, with 163,148,904 shares pledged[9]. - The total number of restricted shares held by Shi Huashan decreased to 163,148,904 shares after a release of 9,088,237 shares during the period[11]. - The company has a total of 190,846,027 restricted shares remaining after the recent release, indicating ongoing management lock-up policies[11]. - The total number of shares held by the top ten shareholders accounts for a significant portion of the company's equity, with Shi Huashan alone holding over 35%[9]. Operational Metrics - Total operating revenue for Q1 2024 was CNY 266,120,434.97, an increase of 4.8% compared to CNY 255,890,736.37 in Q1 2023[17]. - Total operating costs decreased to CNY 199,283,573.88 from CNY 207,666,695.36, representing a reduction of 4.1%[17]. - Research and development expenses were CNY 8,736,382.39, down from CNY 11,327,765.73, indicating a reduction of 22.8%[17]. - Deferred income decreased to CNY 6,768,272.62 from CNY 7,491,251.62, a decline of 9.6%[17]. - The company's cash and cash equivalents increased by 36.13% to CNY 181,793,947.44, up from CNY 133,546,152.31[7]. - Accounts receivable decreased to ¥258,526,033.14 from ¥289,878,555.19, a decline of about 10.8%[13]. - The company's inventory increased to ¥243,177,396.00 from ¥236,780,522.13, an increase of about 2%[13].
汉宇集团:监事会决议公告
2024-04-24 13:14
证券代码:300403 证券简称:汉宇集团 公告编号:2024-009 汉宇集团股份有限公司 第五届监事会第五次会议决议公告 经与会监事认真审议本次会议议案并表决,形成本次监事会决议如下: 1、审议通过了《2023 年年度报告》(全文及摘要) 经审核,监事会认为董事会编制和审核公司 2023 年年度报告的程序符合法 律、行政法规和中国证监会的规定,报告内容真实、准确、完整地反映了公司的 实际情况,不存在任何虚假记载、误导性陈述或者重大遗漏。 表决结果:3 票同意,0 票反对,0 票弃权,表决通过。 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 汉宇集团股份有限公司(以下简称"公司")第五届监事会第五次会议(以 下简称"本次会议")于 2024 年 4 月 24 日以通讯表决的方式召开,本次会议由 监事会主席曹阳先生主持,应参与表决监事 3 人,实际表决监事 3 人。 本次会议通知于 2024 年 4 月 12 日以邮件方式发出,会议召开符合《中华人 民共和国公司法》《公司章程》的规定,会议召开合法、有效。 二、监事会会议审议情况 表决 ...
汉宇集团:未来三年(2022年-2024年)股东回报规划(2024年4月)
2024-04-24 13:14
汉宇集团股份有限公司 未来三年(2022 年-2024 年)股东回报规划 为完善汉宇集团股份有限公司(以下简称"公司")科学、持续、稳定的分 红决策和监督机制,积极回报投资者,引导投资者树立长期投资和理性投资理念, 增加利润分配决策透明度和可操作性,切实保护投资者的合法权益,根据中国证 监会《上市公司监管指引第3 号——上市公司现金分红(2023年修订)》和《公 司章程》的规定,公司董事会结合公司实际情况,制订《未来三年(2022年-2024 年)股东回报规划》(以下简称"本规划"),主要内容如下: 一、制定本规划的考虑因素 公司将着眼于长远和可持续发展,综合分析公司经营发展实际、股东要求和 意愿、社会资金成本、外部融资环境等因素,充分考虑公司目前及未来盈利规模、 现金流量状况、经营发展规划、发展所处阶段、项目投资资金需求、社会资金成 本及外部融资环境等因素,建立对投资者持续、稳定、科学的回报规划与机制, 从而对利润分配做出制度性安排,以保证利润分配政策的连续性和稳定性。 二、本规划的制定原则 本规划遵循《公司法》、《证券法》等法律法规、规范性文件和《公司章程》 的规定,重视对投资者的合理投资回报并兼顾公司当 ...
汉宇集团:董事会决议公告
2024-04-24 13:14
证券代码:300403 证券简称:汉宇集团 公告编号:2024-008 汉宇集团股份有限公司 第五届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 汉宇集团股份有限公司(以下简称"公司")第五届董事会第六次会议(以 下简称"本次会议")于 2024 年 4 月 24 日以通讯表决的方式召开,本次会议由 董事长石华山先生主持,应参与表决董事 9 人,实际表决董事 9 人,公司高级管 理人员列席会议。 本次会议通知于 2024 年 4 月 12 日以邮件方式发出,会议召开符合《中华人 民共和国公司法》《公司章程》的规定,会议召开合法、有效。 二、董事会会议审议情况 经与会董事认真讨论,审议通过以下议案: 1、审议通过《2023年年度报告》(全文及摘要) 公司《2023 年年度报告》、《2023 年年度报告摘要》符合法律法规及相关 规定,报告内容真实、准确、完整地反映了公司 2023 年度的经营情况,不存在 虚假记载、误导性陈述或者重大遗漏。内容详见中国证监会创业板指定信息披露 网站。 表决结果:9 票同意、0 票反 ...
汉宇集团:关于会计政策变更的公告
2024-04-24 13:14
一、会计政策变更概述 汉宇集团股份有限公司 关于会计政策变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 汉宇集团股份有限公司(以下简称"公司")根据中华人民共和国财政部(以 下简称"财政部")颁布的企业会计准则变更相应的会计政策,本次会计政策变 更无需提交公司董事会和股东大会审议,相关企业会计解释的施行对公司财务报 表无重大影响。 证券代码:300403 证券简称:汉宇集团 公告编号:2024-018 本次变更前,公司执行财政部发布的《企业会计准则—基本准则》和各项具 体会计准则、企业会计准则应用指南、企业会计准则解释公告以及其他相关规定。 (三)变更后采用的会计政策 本次会计政策变更后,公司将按照财政部发布的《解释第 16 号》要求执行。 其余未变更部分仍采用财政部前期颁布的《企业会计准则—基本准则》和各项具 体会计准则、企业会计准则应用指南、企业会计准则解释公告以及其他相关规定 执行。 二、会计政策变更对公司的影响 (一)变更原因 2022年11月30日,财政部颁布了《企业会计准则解释第16号》(财会[2022]31 号,以下简称《解释第 16 ...
汉宇集团:公司章程(2024年4月)
2024-04-24 13:12
汉宇集团股份有限公司 章 程 2024 年 4 月 广东·江门 目 录 | 第一章 | 总 则 . | | --- | --- | | 第二章 | 经营宗旨和范围 . | | 第三章 | 股份 . | | 第一节 | 股份发行 | | 第二节 | 股份增减和回购 . | | 第三节 | 股份转让 | | 第四章 股东和股东大会 | | | 第一节 | 股东 | | 第二节 | 股东大会的一般规定 11 | | 第三节 | 股东大会的召集 . | | 第四节 | 股东大会的提案与通知 15 | | 第五节 | 股东大会的召开 . | | 第六节 | 股东大会的表决和决议 . | | 第五章 董事会 | | | 第一节 | 董事 | | 第二节 | 董事会 | | 第三节 | 董事会秘书 | | 第四节 | 独立董事 | | 第六章 经理及其他高级管理人员 | | | 第七章 | 监事会 | | 第一节 监事 | | | 第二节 监事会 | | | 第八章 财务会计制度、利润分配和审计. | | | 第一节 | 财务会计制度 . | | 第二节 | 内部审计 . | | 第三节 会计师事务所的聘任 | | | 第 ...
汉宇集团:关于开展以套期保值为目的的远期结售汇业务、外汇期权业务、外汇掉期业务的公告
2024-04-24 13:12
证券代码:300403 证券简称:汉宇集团 公告编号:2024-014 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示: 1、交易目的、交易品种和交易金额:为规避和防范汇率风险,公司拟开展 以套期保值为目的的远期结售汇业务、外汇期权业务、外汇掉期业务,合计金额 不超过 3.6 亿美元或相同价值的外汇金额。 2、审议程序:2024 年 4 月 24 日,公司召开第五届董事会第六次会议、第 五届监事会第五次会议审议通过了《关于开展以套期保值为目的的远期结售汇业 务、外汇期权业务、外汇掉期业务的议案》,本事项尚需提交公司 2023 年年度 股东大会审议。 3、风险提示:公司拟开展的远期结售汇业务、外汇期权业务、外汇掉期业 务遵循合法、审慎、安全、有效的原则,不从事以投机为目的的上述交易,但开 展衍生品交易会存在汇率波动风险、客户违约风险、回款预测风险等。公司将做 好风险管理工作,按照规定及时履行后续信息披露义务。 汉宇集团股份有限公司(以下简称"公司")于 2024 年 4 月 24 日召开了第 五届董事会第六次会议,审议通过了《关于开展以套期保值为目 ...
汉宇集团(300403) - 2023 Q4 - 年度财报
2024-04-24 13:12
Financial Performance - The company's operating revenue for 2023 was CNY 1,091,413,374.75, representing a 3.20% increase compared to CNY 1,057,566,600.35 in 2022[29]. - Net profit attributable to shareholders for 2023 was CNY 243,958,635.97, a 19.48% increase from CNY 204,189,466.21 in 2022[29]. - The cash flow from operating activities increased by 64.68% to CNY 295,770,600.03 in 2023, compared to CNY 179,597,832.65 in 2022[29]. - Basic earnings per share rose to CNY 0.4046, up 19.49% from CNY 0.3386 in 2022[29]. - Total assets at the end of 2023 were CNY 2,367,540,561.84, a 5.23% increase from CNY 2,249,826,872.72 at the end of 2022[29]. - The net assets attributable to shareholders increased by 6.43% to CNY 1,954,982,656.89 at the end of 2023, compared to CNY 1,836,814,967.72 at the end of 2022[29]. - The company reported a quarterly revenue of CNY 292,672,498.94 in Q4 2023, showing a consistent growth trend throughout the year[31]. - The net profit attributable to shareholders in Q4 2023 was CNY 66,428,191.37, indicating strong performance in the last quarter[31]. - The weighted average return on equity for 2023 was 12.51%, an increase from 11.60% in 2022[29]. Dividend Distribution - The company plans to distribute a cash dividend of 2.5 RMB per 10 shares to shareholders, based on a total of 603,000,000 shares[14]. - The company distributed a cash dividend of 1.3 RMB per 10 shares, totaling 78,390,000 RMB (including tax) for the 2022 fiscal year[145]. - The same cash dividend of 1.3 RMB per 10 shares was approved for the first half of 2023, also totaling 78,390,000 RMB (including tax)[146]. - The cash dividend policy aligns with the company's articles of association and shareholder resolutions[148]. Research and Development - The company is actively investing in R&D to adapt to rapid technological advancements and maintain its competitive edge[13]. - The company has developed new products such as dishwasher circulation pumps and components for electric vehicles, which are expected to enhance market competitiveness[6]. - The company has developed a smart water therapy toilet, which combines features of a smart toilet and a rectal therapy device, and has received medical device certification in China and FDA approval in the US[41]. - The company is developing several new products, including a BLDC drainage pump and an electric vehicle electronic water pump, to expand its market presence[70]. - Research and development expenses amounted to CNY 4,160.57 million, representing 3.81% of operating revenue[57]. - The company has a strong focus on R&D, having developed proprietary technologies for energy-efficient drainage pumps, which has broken foreign monopolies in this area[40]. - The company has launched 15 new authorized patents during the reporting period, bringing the total number of authorized patents to 612[56]. - The company holds 612 authorized patents, including 103 domestic invention patents and 36 overseas invention patents, showcasing its strong R&D capabilities[49]. Market Expansion and Strategy - The company is actively expanding into the new energy vehicle parts sector, focusing on electronic water pumps and charging stations, with products already in mass production and sales[42]. - The company aims to enhance its market share in the household appliance drainage pump sector by improving production capacity and efficiency, and increasing R&D investment[43]. - The global trend towards energy-efficient and environmentally friendly appliances is driving demand for the company's products in developed and emerging markets[39]. - The company has established a nationwide distribution network for its water therapy toilets, leveraging advertising and experiential marketing to expand sales channels[44]. - The company is focusing on enhancing its technological capabilities and product offerings to drive future growth[111]. - The management indicated a positive outlook for 2024, expecting revenue growth driven by new product launches and market penetration[111]. Risk Management - The company acknowledges the risk of raw material price fluctuations impacting operational performance, and it is taking measures to mitigate these risks[12]. - The company faces risks related to the potential loss of core technical personnel, which could impact its R&D capabilities[5]. - The company has identified risks related to underutilization of new production capacity, rising costs, and potential sales risks for new products, and plans to implement strategies to mitigate these risks[95][96]. - The company has established management systems to strengthen risk management and control of derivative transactions[85]. Corporate Governance - The company emphasizes strict compliance with corporate governance regulations, ensuring equal rights for all shareholders and independent operations from the controlling shareholder[102]. - The board of directors is composed of qualified members and operates through specialized committees to enhance decision-making and governance[103]. - The company has established a performance evaluation and incentive mechanism for senior management, promoting transparency and fairness in the hiring process[104]. - The company maintains independence in its operations, assets, and finances from its controlling shareholder, ensuring a complete business system[107]. - The company has conducted multiple board meetings to discuss financial reports and strategic decisions throughout the year[133]. - The company has not reported any dissenting opinions from board members on significant issues during the reporting period[136]. Employee Management - The total number of employees at the end of the reporting period was 1,586, with 857 in the parent company and 729 in major subsidiaries[142]. - The workforce composition includes 958 production personnel, 201 technical personnel, and 194 R&D personnel[142]. - The company has established a competitive salary policy based on market levels and individual performance[143]. - The company has implemented a three-tier training plan to support employee development[144]. Environmental and Social Responsibility - The company actively participates in social responsibility, donating a total of CNY 1.5 million to charitable organizations in 2023[162]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[159]. - The company has committed to maintaining compliance with various legal obligations and has not encountered any violations during the reporting period[166]. Lease Agreements - The company has multiple lease agreements with Han Yu Group for various properties in Jiangmen, with lease terms ranging from 2023 to 2025[189]. - The total leased area includes 2,923 square meters for a factory and 898 square meters for an additional factory space[189]. - The company has a total of 13 lease agreements listed, indicating a strong operational footprint in Jiangmen[189]. - The lease agreements cover various types of properties, including factories and dormitories, reflecting the company's diverse operational needs[189]. Related Party Transactions - The total amount of related party transactions for the year is projected to be 20.78 million RMB, with no transactions exceeding the approved limits[179]. - The company plans to purchase plastic raw materials from a related party, with an estimated amount not exceeding 10 million RMB for the fiscal year 2023[179]. - The company expects to receive rental income and utility fees from related parties, estimated not to exceed 6.5 million RMB and 7.3 million RMB respectively for the fiscal year 2023[179].
汉宇集团:独立董事述职报告-谢泓
2024-04-24 13:12
汉宇集团股份有限公司 独立董事述职报告 (谢泓) 本人(谢泓)担任汉宇集团股份有限公司(以下简称"公司")第四届董事 会独立董事。任职期间,本人严格按照《公司法》《上市公司独立董事规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《公 司章程》《独立董事工作制度》等相关法律、法规、规章制度及规范性文件的规 定和要求,忠实履行独立董事职责,认真审慎地行使公司及股东所赋予的权利, 维护公司和股东尤其是中小股东的利益。 (二)出席董事会专门委员会情况 报告期内,本人任第四届董事会薪酬与考核委员会主任委员、提名委员会委 员、战略委员会委员。 1、董事会薪酬与考核委员会 在担任独立董事期间,本人的任职符合法律法规和规范性文件等规定的独立 性要求,不存在影响独立性的情况。 二、年度履职情况 (一)出席董事会、股东大会情况 2023 年度,本人在公司担任独立董事时间为 2023 年 1 月 1 日至 2023 年 5 月 12 日,期间公司共计召开股东大会 2 次、董事会 4 次。本人出席公司董事会和股 东大会的具体情况如下: 出席董事会及股东大会的情况 | 任职期间 应参加董 | 亲自出席 ...